Novavax Surging On $60M Funding For Covid-19 Vaccine Candidate
Inovio Suing Suppliers Over Covid-19 Vaccine Production
Moderna's (MRNA) Stock Will Surge 80% From Current Levels, Says Analyst
Scientists aim gene-targeting breakthrough against COVID-19
3 “Strong Buy” Penny Stocks That Could See Outsized Returns
AstraZeneca Partners With Accent To Develop Novel Cancer Treatments
Analyst Sounds the Valuation Alarm Bell on Inovio's Hot Stock
From the research lab to your doctor's office – here's what happens in phase 1, 2, 3 drug trials
Think Novavax Has Surged Enough for Now? Think Again, Says 5-Star Analyst
3 "Strong Buy" Biotech Stocks Under $5 With Major Catalysts Approaching
3 'Strong Buy' Biotech Stocks Under $5 That Could Go Boom
How the coronavirus could be prevented from invading a host cell
Atriva takes MEK inhibitor into phase 2 for COVID-19
3 "Strong Buy" Penny Stocks That Offer Massive Potential Gains
Cincinnati children’s HLH research points to treatment for COVID-19 cytokine storms
GSK to produce a billion doses of COVID-19 vaccine booster by 2021
Eli Lilly, Junshi Biosciences To Start Human Testing Of Covid-19 Antibodies By Q2
Merck Joins Race For Covid-19 Vaccine; Shares Rise 4.4% In Pre-Market Trading
Novavax is latest biotech to begin coronavirus vaccine trial
7 "Perfect 10" Stocks to Buy Now
Inovio Can Climb Higher, Says Top Analyst
Novavax’s COVID-19 Vaccine Candidate Could Be the One, Says Top Analyst
Airway Therapeutics, Celonic Group partner to produce AT-100 as candidate for coronavirus
Inovio Pops Almost 10% on ‘Positive’ Preclinical Results For Its Covid-19 Vaccine
A little-known biotech running low on cash looks to get its own $100M IPO from pandemic market
Has Novavax (NVAX) Stock Come Too Far, Too Fast?
Applied DNA Sciences Tackles COVID-19 on Three Fronts; Analyst Says 'Buy'
3 "Strong Buy" Penny Stocks With Triple-Digit Upside
Fate Therapeutics (FATE) Earnings Report Highlights for Q1 2020
Moderna’s COVID-19 Vaccine Candidate Progressing at 'Warp Speed,' Says Top Analyst